BR112014020734A2 - Método para preparar imunoglobulina humana - Google Patents

Método para preparar imunoglobulina humana

Info

Publication number
BR112014020734A2
BR112014020734A2 BR112014020734A BR112014020734A BR112014020734A2 BR 112014020734 A2 BR112014020734 A2 BR 112014020734A2 BR 112014020734 A BR112014020734 A BR 112014020734A BR 112014020734 A BR112014020734 A BR 112014020734A BR 112014020734 A2 BR112014020734 A2 BR 112014020734A2
Authority
BR
Brazil
Prior art keywords
human immunoglobulin
preparation
iii
anion exchange
exchange chromatography
Prior art date
Application number
BR112014020734A
Other languages
English (en)
Other versions
BR112014020734B1 (pt
Inventor
Yang Huichuan
Lv Jiacheng
Liang Hong
Wang Yan
Wu Peng
Li Zelin
Lan Xueyuan
Original Assignee
Chengdu Rongsheng Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Rongsheng Pharmaceuticals Co Ltd filed Critical Chengdu Rongsheng Pharmaceuticals Co Ltd
Publication of BR112014020734A2 publication Critical patent/BR112014020734A2/pt
Publication of BR112014020734B1 publication Critical patent/BR112014020734B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

MÉTODO PARA PREPARAR IMUNOGLOBULINA HUMANA. A presente invenção fornece um método para preparar imunoglobulina humana, que compreende tais etapas como: dissolução de componente I+ II+III de Cohn ou componente II+III de Cohn, precipitação de ácido caprílico, cromatografia de troca de ânions de primeira etapa, precipitação de IgM, cromatografia de troca de ânions de segunda etapa, ultrafiltração ou diálise, preparo e inativação de vírus; como resultado, imunoglobulina humana de pureza alta é obtida através do preparo. É fornecida, ainda, imunoglobulina humana preparada através do método e uma composição farmacêutica. O método de preparo da presente invenção é simples, tem um custo baixo e tem uma boa expectativa de aplicação industrial.
BR112014020734-8A 2012-02-22 2013-02-22 método para preparar imunoglobulina humana BR112014020734B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201210041098.6 2012-02-22
CN2012100410986A CN102532307B (zh) 2012-02-22 2012-02-22 一种制备人免疫球蛋白的方法
PCT/CN2013/071754 WO2013123889A1 (zh) 2012-02-22 2013-02-22 一种制备人免疫球蛋白的方法

Publications (2)

Publication Number Publication Date
BR112014020734A2 true BR112014020734A2 (pt) 2017-08-22
BR112014020734B1 BR112014020734B1 (pt) 2021-03-02

Family

ID=46340458

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014020734-8A BR112014020734B1 (pt) 2012-02-22 2013-02-22 método para preparar imunoglobulina humana

Country Status (7)

Country Link
CN (1) CN102532307B (pt)
BR (1) BR112014020734B1 (pt)
CO (1) CO7141451A2 (pt)
IN (1) IN2014DN07228A (pt)
PH (1) PH12014501909B1 (pt)
RU (1) RU2614119C9 (pt)
WO (1) WO2013123889A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104356231B (zh) * 2014-11-10 2017-08-08 北海开元生物科技有限公司 一种有效去除人免疫球蛋白多聚体的方法
CN105126100B (zh) * 2015-09-23 2021-01-26 成都蓉生药业有限责任公司 一种富含IgM的人免疫球蛋白制剂及其制备方法
AU2016231646B2 (en) * 2016-09-26 2021-04-08 Instituto Grifols, S.A. Method for the preparation of immunoglobulins
CN108101981B (zh) * 2018-01-15 2019-06-04 四川远大蜀阳药业有限责任公司 一种静注免疫球蛋白的生产工艺
CN109575129B (zh) * 2018-12-29 2022-04-26 贵州泰邦生物制品有限公司 一种静注人免疫球蛋白的制备工艺
CN110330565B (zh) * 2019-07-11 2021-07-30 国药集团武汉血液制品有限公司 从血浆分离组分ⅰ和ⅲ中提取静注人免疫球蛋白的方法
CN111234009A (zh) * 2020-01-20 2020-06-05 华兰生物工程重庆有限公司 一种去除特异性人免疫球蛋白中IgA和IgM的层析工艺
BE1029863B1 (nl) * 2022-05-10 2023-05-12 Prothya Biosolutions Belgium WERKWIJZEN VOOR HET PRODUCEREN VAN IMMUNOGLOBULINE G (IgG) PREPARATEN EN/OF OPLOSSINGEN

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
JPS58180433A (ja) * 1982-04-16 1983-10-21 Fujirebio Inc 免疫グロブリンから抗補体作用物質の除去法
TR200100303T2 (tr) * 1998-06-09 2001-06-21 Statens Serum Institut Damardan uygulanacak immünoglobülinler üretmek için yöntem ve başka immünoglobülin ürünleri.
ES2606078T3 (es) * 2004-06-07 2017-03-17 Therapure Biopharma Inc. Aislamiento de proteínas del plasma
RU2361612C1 (ru) * 2007-12-21 2009-07-20 Федеральное Государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Иммуноглобулиновая основа для иммунобиологических препаратов и способ ее получения, суппозитории и мазь для профилактики и терапии бактериальных и вирусных заболеваний
KR101464032B1 (ko) * 2009-05-27 2014-11-27 백스터 인터내셔널 인코포레이티드 피하 사용을 위한 고 농축 면역글로불린 제제의 제조 방법
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом

Also Published As

Publication number Publication date
CN102532307A (zh) 2012-07-04
IN2014DN07228A (pt) 2015-04-24
PH12014501909A1 (en) 2014-11-24
CO7141451A2 (es) 2014-12-12
RU2614119C2 (ru) 2017-03-22
WO2013123889A1 (zh) 2013-08-29
BR112014020734B1 (pt) 2021-03-02
RU2614119C9 (ru) 2017-08-15
PH12014501909B1 (en) 2014-11-24
RU2014135665A (ru) 2016-04-10
CN102532307B (zh) 2013-06-12

Similar Documents

Publication Publication Date Title
BR112014020734A2 (pt) Método para preparar imunoglobulina humana
BR112017027831A2 (pt) derivados de hidroxiácido, um processo para sua preparação e composições farmacêuticas contendo-os
CY1121150T1 (el) Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας
BR112015009395A2 (pt) processo para preparação de derivados do ácido biliar
EA201491672A1 (ru) Гетероциклильные соединения как ингибиторы mek
BRPI0918360A8 (pt) Composto, composição farmacêutica e usos de um composto
BR112018013218A2 (pt) derivado de acrilanilida, método de preparação e aplicação do mesmo na farmácia
BR112015005168A2 (pt) Derivados de c17-alcanodiila e alquenodiila de ácido oleanólico e métodos de uso dos mesmos
BR112015014678A2 (pt) lactamas fundidas com arila e heteroarila
PH12014502524B1 (en) Carboxylic acid compounds
BR112015026023A2 (pt) derivados de 2- aminopirido[4,3-d]pirimidin-5-ona e seu uso como inibidores de wee-1
BR112017020837A2 (pt) compostos de carbamoilpiridona policíclicos e seu uso farmacêutico
CR20170590A (es) Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen
BR112015002152A2 (pt) pirróis substituídos ativos como inibidores de quinases
BR112015011158A2 (pt) triazolopirazina
BR112015031913A2 (pt) processo para a fabricação de amino-benzoxazinonas 4-propargilatadas e sua utilização
BR112015026473A2 (pt) formulação de um meio de contraste e seu processo de preparação associado
BR112016001783A2 (pt) compostos e composições como inibidores de mek
BR112015016325A2 (pt) Composto, composição farmacêutica, e, usos de uma composição, composto, pró-droga ou sal farmaceuticamente aceitável do mesmo
CL2015001319A1 (es) Compuestos derivados de n-(piridin-2-il)pirimidin-4-amina que contienen un grupo sulfoximina; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y metodo para la preparacion de compuestos.
BR112015023829A2 (pt) composto de amidina e seu uso
BR112015004178A2 (pt) gluconato de clorexidina solubilizado em um monoacilglicerídeo hidrofóbico
BR112015027187A2 (pt) processo de fabricação de uma composição antiperspirante aquosa e método de obtenção de um benefício de antiperspirância
NI201200195A (es) Procedimiento de preparación de la sal de l - arginina de perindoprilo
BR112013024965A2 (pt) composto, composição farmacêutica, método de tratamento de infecções virais, e, processo para preparar um composto

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/02/2013, OBSERVADAS AS CONDICOES LEGAIS.